Outcomes of live births
| Event . | All pregnancies . | Clinical trials . | Administration during established pregnancies . |
|---|---|---|---|
| Total no. of live births | 91 | 31 | 20 |
| Full-term infants, n | 68 | 22 | 11 |
| Twins, no. of sets | 2 | 0 | 0 |
| Premature delivery (< 37 wk), n | 16*† | 9* | 9 |
| Hematologic abnormalities, n | 11 | 1 | 7 |
| B-cell depletion, n | 4 | 0 | 3 |
| Lymphopenia, n | 3 | 0 | 1 |
| Neutropenia and anemia, n | 1 | 0 | 1 |
| Thrombocytopenia, n | 3 | 1 | 2 |
| Low birth weight, n | 1 | 0 | 0 |
| Congenital abnormalities, n | 3 | 1 | 0 |
| Club foot, n | 1 of twin pair | 0 | 0 |
| VSD/PFO/PDA, n | 1 | 1 | 0 |
| Turner syndrome, n | 1‡ | 0 | 1 |
| Neonatal infections, n | 4 | 2 | 1 |
| Fever at 3 weeks of age, n | 1 | 1 | 0 |
| Neonatal bronchiolitis, n | 1 | 0 | 0 |
| CMV hepatitis, n | 1 | 0 | 1 |
| Acute chorioamnionitis, n | 1 | 1 | 0 |
| Neonatal death (unknown cause), n | 1 | 1 | 0 |
| Event . | All pregnancies . | Clinical trials . | Administration during established pregnancies . |
|---|---|---|---|
| Total no. of live births | 91 | 31 | 20 |
| Full-term infants, n | 68 | 22 | 11 |
| Twins, no. of sets | 2 | 0 | 0 |
| Premature delivery (< 37 wk), n | 16*† | 9* | 9 |
| Hematologic abnormalities, n | 11 | 1 | 7 |
| B-cell depletion, n | 4 | 0 | 3 |
| Lymphopenia, n | 3 | 0 | 1 |
| Neutropenia and anemia, n | 1 | 0 | 1 |
| Thrombocytopenia, n | 3 | 1 | 2 |
| Low birth weight, n | 1 | 0 | 0 |
| Congenital abnormalities, n | 3 | 1 | 0 |
| Club foot, n | 1 of twin pair | 0 | 0 |
| VSD/PFO/PDA, n | 1 | 1 | 0 |
| Turner syndrome, n | 1‡ | 0 | 1 |
| Neonatal infections, n | 4 | 2 | 1 |
| Fever at 3 weeks of age, n | 1 | 1 | 0 |
| Neonatal bronchiolitis, n | 1 | 0 | 0 |
| CMV hepatitis, n | 1 | 0 | 1 |
| Acute chorioamnionitis, n | 1 | 1 | 0 |
| Neonatal death (unknown cause), n | 1 | 1 | 0 |